DEB-BACE is a novel therapy for advanced lung cancer, and many studies have reported the efficacy of DEB-BACE for untreated NSCLC (Liu J et al., 2021; Liu XF et al., 2021). The gene discussed is BACE1; the disease is lung cancer.